Cargando…

SARS: screening, disease associations, and response

Detalles Bibliográficos
Autor principal:	Sloan, Richard EG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2003
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134659/ https://www.ncbi.nlm.nih.gov/pubmed/12788593 http://dx.doi.org/10.1016/S0140-6736(03)13507-6

Ejemplares similares

Testing for responses to the wrong SARS-CoV-2 antigen?
por: Rosadas, Carolina, et al.
Publicado: (2020)

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
por: Sutton, Desmond, et al.
Publicado: (2020)

Authors' response to “Response to Diffuse Trophoblast Damage is the Hallmark of SARS-CoV-2-associated fetal demise”
por: Nadal, Alfons, et al.
Publicado: (2022)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Screening faecal microbiota transplant donors for SARS-CoV-2 by molecular testing of stool is the safest way forward
por: Green, Christopher A, et al.
Publicado: (2020)

Response to “Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise.”
por: Torous, Vanda F., et al.
Publicado: (2022)

Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
por: Prentice, Ralley E., et al.
Publicado: (2020)

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
por: Zingone, Fabiana, et al.
Publicado: (2020)

Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity
por: Auteri, Giuseppe, et al.
Publicado: (2022)

Universal screening identifies asymptomatic carriers of SARS-CoV-2 among pregnant women in India
por: Waghmare, Rakesh, et al.
Publicado: (2021)

SARS: screening, disease associations, and response
por: Baker, Simon J
Publicado: (2003)

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
por: Al‐Janabi, A., et al.
Publicado: (2021)

SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
por: Hasan, Tasnim, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 in people living with HIV
por: Yamamoto, Shinya, et al.
Publicado: (2021)

Proteomic characterization of Omicron SARS-CoV-2 host response
por: Bao, Jianfeng, et al.
Publicado: (2022)

Diabetic retinopathy screening during the coronavirus disease 2019 pandemic
por: Shih, Kendrick C., et al.
Publicado: (2020)

Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry
por: Iwasaki, Yudai, et al.
Publicado: (2020)

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
por: Anichini, Gabriele, et al.
Publicado: (2021)

The ability of the neonatal immune response to handle SARS-CoV-2 infection
por: Götzinger, Florian, et al.
Publicado: (2021)

Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Glatzel, Markus, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Egervari, Kristof, et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis
por: Aldana, Isabella, et al.
Publicado: (2022)

Response to Gelb et al.: “Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs”
por: Millington, David S.
Publicado: (2017)

Author response to “lack of benefit from low dose computed tomography in screening for lung cancer”
por: Huang, Kai-Lin, et al.
Publicado: (2020)

Attenuation of antibody response to SARS-CoV-2 in a patient on ocrelizumab with hypogammaglobulinemia
por: Conte, William L
Publicado: (2020)

Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome
por: Wiegand, Sarah E., et al.
Publicado: (2021)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2
por: Fang, Zhenhao, et al.
Publicado: (2022)

Guillain–Barré Syndrome Associated with SARS-CoV-2
por: Toscano, Gianpaolo, et al.
Publicado: (2020)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
por: Edara, Venkata-Viswanadh, et al.
Publicado: (2021)

The right to be screened: Identifying and addressing inequities in genetic screening
por: Swami, Nishwant, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 vaccination following typical and three-dose dosing schedules in multiple sclerosis patients treated with disease modifying therapies
por: Wallach, Asya I., et al.
Publicado: (2022)

Response to “Assessing the role of Piscine orthoreovirus in disease and the associated risk for wild Pacific salmon”
por: Polinski, Mark P., et al.
Publicado: (2023)

Alzheimer's disease identified in a patient with bullous pemphigoid by dementia screening scales
por: Zhao, Wen-Ling, et al.
Publicado: (2019)

Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response
por: Cao, Zengguo, et al.
Publicado: (2021)

The ability of the neonatal immune response to handle SARS-CoV-2 infection – Authors' reply
por: Gale, Chris, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9m50kcb8fhgm1iv2hsc3glvcgt